BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15207770)

  • 1. A theoretical analysis of long-term bisphosphonate effects on trabecular bone volume and microdamage.
    Nyman JS; Yeh OC; Hazelwood SJ; Martin RB
    Bone; 2004 Jul; 35(1):296-305. PubMed ID: 15207770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
    Seeman E
    Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib.
    Komatsubara S; Mori S; Mashiba T; Li J; Nonaka K; Kaji Y; Akiyama T; Miyamoto K; Cao Y; Kawanishi J; Norimatsu H
    J Bone Miner Res; 2004 Jun; 19(6):999-1005. PubMed ID: 15125797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted bone remodeling involves BMU steering as well as activation.
    Martin RB
    Bone; 2007 Jun; 40(6):1574-80. PubMed ID: 17398173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra.
    Komatsubara S; Mori S; Mashiba T; Ito M; Li J; Kaji Y; Akiyama T; Miyamoto K; Cao Y; Kawanishi J; Norimatsu H
    J Bone Miner Res; 2003 Mar; 18(3):512-20. PubMed ID: 12619936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A computational model for cortical endosteal surface remodeling induced by mechanical disuse.
    Gong H; Zhang M
    Mol Cell Biomech; 2010 Mar; 7(1):1-11. PubMed ID: 20806719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know.
    Allen MR; Burr DB
    Bone; 2011 Jul; 49(1):56-65. PubMed ID: 20955825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling.
    Riggs BL; Parfitt AM
    J Bone Miner Res; 2005 Feb; 20(2):177-84. PubMed ID: 15647810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone remodeling at the iliac crest can predict the changes in remodeling dynamics, microdamage accumulation, and mechanical properties in the lumbar vertebrae of dogs.
    Mashiba T; Hui S; Turner CH; Mori S; Johnston CC; Burr DB
    Calcif Tissue Int; 2005 Sep; 77(3):180-5. PubMed ID: 16265598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?
    Seeman E
    Bone; 2007 Sep; 41(3):308-17. PubMed ID: 17644058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys.
    Yamagami Y; Mashiba T; Iwata K; Tanaka M; Nozaki K; Yamamoto T
    Bone; 2013 May; 54(1):1-7. PubMed ID: 23356990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictions on preserving bone mass in knee arthroplasty with bisphosphonates.
    Nyman JS; Rodrigo JJ; Hazelwood SJ; Yeh OC; Martin RB
    J Arthroplasty; 2006 Jan; 21(1):106-13. PubMed ID: 16446194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perforation of cancellous bone trabeculae by damage-stimulated remodelling at resorption pits: a computational analysis.
    McNamara LM; Prendergast PJ
    Eur J Morphol; 2005; 42(1-2):99-109. PubMed ID: 16123029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of bone quality. Bone quality and osteoporosis treatment].
    Mashiba T
    Clin Calcium; 2008 Mar; 18(3):300-7. PubMed ID: 18310816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A stochastic analysis of iliac trabecular bone dynamics.
    Reeve J
    Clin Orthop Relat Res; 1986 Dec; (213):264-78. PubMed ID: 3780102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the onset and propagation of trabecular bone microdamage during low-cycle fatigue.
    Kosmopoulos V; Schizas C; Keller TS
    J Biomech; 2008; 41(3):515-22. PubMed ID: 18076887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative roles of microdamage and microfracture in the mechanical behavior of trabecular bone.
    Yeh OC; Keaveny TM
    J Orthop Res; 2001 Nov; 19(6):1001-7. PubMed ID: 11780997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone Cell Biology Assessed by Microscopic Approach. The effects of bisphosphonates on bone remodeling, microdamage accumulation and fracture repair process].
    Mashiba T
    Clin Calcium; 2015 Oct; 25(10):1537-40. PubMed ID: 26412734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theoretical analysis of alendronate and risedronate effects on canine vertebral remodeling and microdamage.
    Wang X; Erickson AM; Allen MR; Burr DB; Martin RB; Hazelwood SJ
    J Biomech; 2009 May; 42(7):938-44. PubMed ID: 19285313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.